摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride | 374799-83-4

中文名称
——
中文别名
——
英文名称
[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride
英文别名
2-[(17-fluoro-13-oxa-3-thiatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),2(6),4,7,9,11,15,17-octaen-4-yl)methoxy]-N,N-dimethylethanamine;hydrochloride
[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride化学式
CAS
374799-83-4
化学式
C21H20FNO2S*ClH
mdl
——
分子量
405.921
InChiKey
DLFUMCMMBMFQDT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.83
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    49.9
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Benzofuran derivatives, their production and use
    申请人:——
    公开号:US20020160996A1
    公开(公告)日:2002-10-31
    Compounds represented by the formula: 1 wherein R 1 and R 2 are hydrogen atom, a hydrocarbon group or a heterocyclic group, or R 1 and R 2 may form, together with the adjacent carbon atom, a 3- to 8-membered homocyclic or heterocyclic ring, W indicates (i) a group represented by the formula: 2 wherein ring B indicates a 5- to 7-membered ring, or (ii) a group represented by the formula: 3 wherein R 4 indicates (1) an aliphatic hydrocarbon group, which may be substituted with an aromatic group, or (2) an acyl group containing an aromatic group, R 5 is hydrogen atom, a C 1-6 alkyl, or an acyl group, provided that, when W is Wa, R 3 is hydrogen atom, a hydrocarbon group or a heterocyclic group, when W is Wb, R 3 indicates a C 6-14 aryl group, or salts thereof or prodrugs thereof have an excellent action to inhibit neurodegeneration and the like as well as an excellent brain penetrability and are low in the toxicity, thereby being useful as prophylactic or therapeutic drugs for nerve degenerative diseases and the like.
    由以下公式代表的化合物: 其中 R1 和 R2 是氢原子、烃基或杂环基,或者 R1 和 R2 可以与相邻的碳原子一起形成 3 至 8 个成员的同环或杂环环,W 表示 (i) 由以下公式代表的基团: 其中环 B 表示一个 5 至 7 个成员的环,或者 (ii) 由以下公式代表的基团: 其中 R4 表示 (1) 可以用芳香基取代的脂肪烃基,或者 (2) 含有芳香基的酰基,R5 是氢原子、C1-6 烷基或酰基,提供当 W 是 Wa 时,R3 是氢原子、烃基或杂环基,当 W 是 Wb 时,R3 表示一个 C6-14 芳基,或其盐或前药具有优异的抑制神经退行性等作用,以及出色的脑透过性,毒性低,因此可用作预防或治疗神经退行性疾病等的药物。
  • Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
    申请人:Pliva farmaceutska industrija, dionicko drustvo
    公开号:US20030153750A1
    公开(公告)日:2003-08-14
    The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-&agr;) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
    本发明涉及由公式I表示的二苯并蓝化合物,以及它们的制药制剂,用于抑制哺乳动物在所有过度分泌这些介质的疾病和情况中的肿瘤坏死因子α(TNF-α)和白细胞介素1(IL-1)。本发明的化合物还表现出镇痛作用,可用于缓解疼痛。
  • Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
    申请人:——
    公开号:US20040034049A1
    公开(公告)日:2004-02-19
    An agent for promoting the proliferation or differentiation of a stem cell and/or neural progenitor cell, comprising a compound represented by Formula: 1 wherein each of R 1 and R 2 is H, a hydrocarbon group or a heterocyclic group, or taken together with the adjacent carbon atom to form a ring, R 3 is H, a hydrocarbon group or a heterocyclic group, W is a group represented by Formula: 2 wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring, R 4 is an acyl group having an aliphatic hydrocarbon group, which is substituted by an aromatic group and may have a further substitutent, or aromatic group, R 5 is H, C 1-6 alkyl or acyl, R 4c is an aromatic group, an aliphatic hydrocarbon group or acyl, and X is O or S; Y is O, S or NH, Ring C is an optionally substituted benzene ring, or a salt or prodrug thereof is provided.
    一种用于促进干细胞和/或神经前体细胞增殖或分化的药剂,包括由公式1表示的化合物,其中R1和R2中的每一个是H、烃基或杂环基,或与相邻的碳原子结合形成环,R3是H、烃基或杂环基,W是由公式2表示的基团,其中环A是可选取代的苯环,环B是可选取代的含氮5-至7元杂环环,R4是取代芳香基的脂肪烃基的酰基,可以有进一步的取代基,或芳香基,R5是H、C1-6烷基或酰基,R4是芳香基、脂肪烃基或酰基,X是O或S;Y是O、S或NH,环C是可选取代的苯环,或其盐或前药。
  • Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells
    申请人:Okawa Shigenori
    公开号:US20090012081A1
    公开(公告)日:2009-01-08
    An agent for promoting the proliferation or differentiation of a stem cell and/or neural progenitor cell, comprising a compound represented by Formula: wherein each of R 1 and R 2 is H, a hydrocarbon group or a heterocyclic group, or taken together with the adjacent carbon atom to form a ring, R 3 is H, a hydrocarbon group or a heterocyclic group, W is a group represented by Formula: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring, R 4 is an acyl group having an aliphatic hydrocarbon group, which is substituted by an aromatic group and may have a further substitutent, or aromatic group, R 5 is H, C 1-6 alkyl or acyl, R 4c is an aromatic group, an aliphatic hydrocarbon group or acyl, and X is O or S; Y is O, S or NH, Ring C is an optionally substituted benzene ring, or a salt or prodrug thereof is provided.
    一种用于促进干细胞和/或神经祖细胞增殖或分化的药剂,包括由下式表示的化合物:其中R1和R2中的每一个是H、烃基或杂环基,或与相邻的碳原子结合形成环,R3是H、烃基或杂环基,W是由下式表示的基团:其中环A是可选取代的苯环,环B是可选取代的含氮杂环5-至7-元环,R4是取代芳基的脂肪族烃基的酰基,可以具有进一步的取代基或芳基,或者是芳基,R5是H、C1-6烷基或酰基,R4是芳基、脂肪族烃基或酰基,X是O或S;Y是O、S或NH,环C是可选取代的苯环,或其盐或前药。
  • PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1323716B1
    公开(公告)日:2009-01-14
查看更多